Park MH, Tolman DE, Kimball PM.
The impact of race and HLA matching on long-term survival following
cardiac transplantation.
Transplant Proc 1997;29(1-2):1460-3.
The purpose of this study was to examine the impact of recipient race
on long-term cardiac survival and to measure the effect of HLA matching
on Caucasian and African-American survival rates following transplantation.
Data were collected from 336 consecutive patients who underwent orthotropic
heart transplantation at two hospitals during the period from March 1983
to July 1994.
African Americans were transplanted at a significantly younger age than
Caucasians (39.1 years for African Americans and 48.2 years for Caucasians).
It is a limitation of this study that the sample size did not permit adjustment
by age, as older age is a risk factor for early mortality, thus possibly
influencing racial patterns in these data. Additionally, the distribution
of disease etiology differed by racial group (Caucasians were more likely
to have coronary artery disease and African Americans were more likely
to have idiopathic cardiomyopathy). Since these data showed a trend survival
pattern related to disease etiology (African Americans with CAD had a
lower survival rate than Caucasians with CAD), the inability to adjust
for disease etiology (again due to the small sample size) was also potentially
problematic.
African Americans received more poorly matched and fewer moderately matched
hearts than Caucasians. The 10-year patient survival was lower for African
Americans than Caucasians. HLA compatibility at the class I loci modestly
improved survival for Caucasians, but class II matching had no effect
on their survival. Match for either class I or class II did not significantly
improve survival for African Americans. When stratified by matching, there
was a modest difference in survival between the two racial groups among
those who received poorly matched class I allografts (African American
survival was inferior to that of Caucasians), but there were no similar
findings among poorly matched class II allografts.
The authors conclude that African American survival is lower than that
of Caucasians and this disparity might be even larger if covariates were
appropriately controlled. Unlike previous studies, which evaluated short
term survival, this study showed that long term survival was associated
with class I loci matching rather than class II matching. Finally, class
I matching was only beneficial to Caucasians. "Although more African
Americans received poorly matched hearts, it is clinically irrelevant
to survival and suggests that nonimmunologic factors may be of greater
significance for this ethnic group." In contrast Caucasians are immunologically
advantaged by matching, "a modest gain that does not justify matching
in its current form as a prerequisite to heart allocation."
The small sample size and the limited assessment of clinical and social
factors that might be associated with survival are limitations of this
study.